References
- Meena JP, Brijwal M, Seth R, et al. Prevalence and clinical outcome of respiratory viral infections among children with cancer and febrile neutropenia. Pediatr Hematol Oncol. 2019;36(6):330–343. doi:10.1080/08880018.2019.1631920.
- Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. JCO. 2017;35(18):2082–2094. doi:10.1200/JCO.2016.71.7017.
- National Institue for Health and Clinical Excellence. 2012. Neutropenic sepsis. http://guidance.nice.org.uk/CG/Wave23/11.
- Bate J, Gibson F, Selwood K, et al. A reaudit of current febrile neutropenia practice in UK paediatric oncology centres prior to implementation of NICE guidance. Arch Dis Child. 2013;98(4):315–316. doi:10.1136/archdischild-2013-303810.
- Herd F, Bate J, Chisholm J, et al. Variation in practice remains in the UK management of paediatric febrile neutropenia. Arch Dis Child. 2016;101(4):410–411. doi:10.1136/archdischild-2015-310294.
- Morgan JE, Phillips B. Winter 2017 children's cancer and leukaemia group febrile neutropenia audit. Arch Dis Child. 2018;103(12):1187. doi:10.1136/archdischild-2018-315249.